Literature DB >> 1245596

Parameters of the three-pool model of the turnover of plasma cholesterol in normal and hyperlipidemic humans.

F R Smith, R B Dell, R P Noble, D S Goodman.   

Abstract

Long-term studies (32-49 wk) of the turnover of plasma cholesterol were conducted in 24 subjects. Eight subjects were normilipidemic, six had hypercholesterolemia, eight had hypercholesterolemia and hypertriglyceridemia, and two had hypertriglyceridemia alone. 10 of the hyperlipidemic patients had a definite familial disorder. In all subjects (except one for whom complete data were not available), the same three-pool model previously described gave the best fit for the data. The parameters of the three-pool model observed in the normal subjects were compared with the model parameters found in the patients with the different kinds of hyperlipidemia. In addition, single and multiple regression analyses were conducted to explore the relationships between the model parameters and various physiological variables, including age, body size, and serum lipid concentrations. Using this approach, significant differences between groups, or correlations with serum lipid levels were seen for several parameters of the three-pool model: the production rate (PR); the size of the rapidly exchanging pool 1 (M1); all estimates of the size of the most slowly equilibrating pool 3 (M3); and the rate constant k21. The PR in normal subjects (1.14 +/- 0.19 g/day, mean +/- SD) was not significantly different from that found in patients with hypercholesterolemia, with or without hypertriglyceridemia. The major determinant of cholesterol PR was overall body size, expressed either as total body weight or as surface area. The correlations between PR and indices of adiposity (percent ideal weight and excess weight), although statistically significant, were much weaker in this nonobese population. After adjustment for body size variation, cholesterol PR was not correlated with the serum cholesterol concentration but was probably (P less than 0.05) correlated with the triglyceride concentration. When the two patients with very high triglyceride concentrations were excluded, however, no correlation was observed between adjusted PR and triglyceride level. It is probable that hypertriglyceridemic patients represent a heterogeneous population, in which the majority do not show increased cholesterol PR. M1 was correlated with all body size variables, but most strongly with excess weight. After adjusting for the effects of body size, M1 was also correlated and triglyceride. Major differences were found in the relationships between the physiological variables and the sizes of pools 2 and 3. M2 was correlated neither with any of the indices of body size or adiposity, nor with the serum levels of either cholesterol or triglyceride. In contrast, all estimates of M3 were correlated with indices of adiposity (but not of overall body size) and with the serum cholesterol concentration. Thus, the amount of cholesterol in slowly equilibrating tissue sites appears to particularly increase with elevations of the serum cholesterol level. The results also confirm previous data that adipose tissue cholesterol is an important part of pool 3.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1245596      PMCID: PMC436633          DOI: 10.1172/JCI108253

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol.

Authors:  A V CHOBANIAN; W HOLLANDER
Journal:  J Clin Invest       Date:  1962-09       Impact factor: 14.808

2.  Synthesis of cholesterol in hypercholesterolemia and its relationship to plasma trigylcerides.

Authors:  H S Sodhi; B J Kudchodkar
Journal:  Metabolism       Date:  1973-07       Impact factor: 8.694

3.  Catabolism of cholesterol in hypercholesterolemia and its relationship to plasma triglycerides.

Authors:  H S Sodhi; B J Kudchodkar
Journal:  Clin Chim Acta       Date:  1973-06-28       Impact factor: 3.786

4.  Electrophoretic separation of plasma lipoproteins in agarose gel.

Authors:  R P Noble
Journal:  J Lipid Res       Date:  1968-11       Impact factor: 5.922

5.  Differences in bile acid excretion in subjects with hypercholesterolaemia, hypertriglyceridaemia and overweight.

Authors:  P J Nestel; J D Hunter
Journal:  Aust N Z J Med       Date:  1974-10

6.  Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.

Authors:  S M Grundy
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

7.  Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;.

Authors:  K Einarsson; K Hellström; M Kallner
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

8.  The turnover of cholesterol in human atherosclerotic arteries.

Authors:  S N Jagannathan; W E Connor; W H Baker; A K Bhattacharyya
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

9.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

10.  The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia.

Authors:  T Langer; W Strober; R I Levy
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

View more
  11 in total

1.  In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.

Authors:  Adriaan G Holleboom; Lily Jakulj; Remco Franssen; Julie Decaris; Menno Vergeer; Joris Koetsveld; Jayraz Luchoomun; Alexander Glass; Marc K Hellerstein; John J P Kastelein; G Kees Hovingh; Jan Albert Kuivenhoven; Albert K Groen; Scott M Turner; Erik S G Stroes
Journal:  J Lipid Res       Date:  2013-05-06       Impact factor: 5.922

2.  Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.

Authors:  I J Goldberg; S Holleran; R Ramakrishnan; M Adams; R H Palmer; R B Dell; D S Goodman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

3.  On determining the extent of side-pool synthesis in a three-pool model for whole body cholesterol kinetics.

Authors:  R Ramakrishnan; R B Dell; D S Goodman
Journal:  J Lipid Res       Date:  1981-11       Impact factor: 5.922

4.  Dietary Iron Repletion Stimulates Hepatic Mobilization of Vitamin A in Previously Iron-Deficient Rats as Determined by Model-Based Compartmental Analysis.

Authors:  Yaqi Li; Cheng-Hsin Wei; Michael H Green; A Catharine Ross
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

5.  Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites.

Authors:  C C Schwartz; M Berman; Z R Vlahcevic; L G Halloran; D H Gregory; L Swell
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

6.  Simvastatin and bezafibrate: effects on serum lipoproteins and lecithin: cholesterol acyltransferase activity in familial hypercholesterolaemia.

Authors:  P Weisweiler
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Immunological and immunoassay studies of the binding protein for vitamin D and its metabolites in human serum.

Authors:  M Imawari; D S Goodman
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

8.  Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate.

Authors:  C C Schwartz; L A Zech; J M VandenBroek; P S Cooper
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

9.  Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima-Media Thickness in Humans.

Authors:  Xiaobo Lin; Susan B Racette; Lina Ma; Michael Wallendorf; Victor G Dávila-Román; Richard E Ostlund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-10-05       Impact factor: 8.311

Review 10.  The Interpretation of Cholesterol Balance Derived Synthesis Data and Surrogate Noncholesterol Plasma Markers for Cholesterol Synthesis under Lipid Lowering Therapies.

Authors:  Frans Stellaard; Dieter Lütjohann
Journal:  Cholesterol       Date:  2017-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.